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Abstract
We investigated whether the repulsive SLIT/ROBO pathway is expressed in the endometrium and
is negatively regulated during implantation. We also examined whether deficient expression in the
Fallopian tube (FT) may predispose to ectopic pregnancy (EP). Endometrium (n=21) and FT
(n=17) were collected across the menstrual cycle from fertile women with regular cycles. FT (n=6)
was obtained from women with EP and decidualised endometrium (n=6) was obtained from
women undergoing termination. SLIT/ROBO expression was quantified by RT-PCR and protein
localised by immunohistochemistry. The regulation of SLIT/ROBO expression in vitro, by sex
steroids and hCG, was assessed in endometrial (hTERT-EEpC) epithelial cells, and the effects of
Chlamydia trachomatis (CT) infection and smoking was studied in oviductal (OE-E6/E7)
epithelial cells. Endometrial SLIT3 was highest in the mid-secretory phase (P=0.0003) and
SLIT1,2 and ROBO1 showed a similar trend. ROBO2 was highest in proliferative phase
(P=0.027) and ROBO3,4 showed a similar trend. SLIT2,3 and ROBO1,4 were lower in decidua
compared to mid-secretory endometrium (P<0.05). SLITs and ROBOs, excepting ROBO2, were
expressed in FT but there were no differences across the cycle or in EP. SLIT/ROBO proteins
were localised to endometrial and FT epithelium. Treatment of hTERT-EEpC with a combination
of estradiol and medroxyprogesterone acetate inhibited ROBO1 expression (P<0.01) but hCG had
no effect. Acute treatment of OE-E6/E7 with smoking metabolite, cotinine, and CT had no effect.
These findings imply a regulated role for the endometrial SLIT/ROBO interaction during normal
development and pregnancy but that it may not be important in the aetiology of ectopic pregnancy.
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Introduction
The Roundabout (ROBO) genes encode transmembrane receptors for their ligands, the SLIT
proteins. There are three SLIT (1-3) proteins that bind to and activate each of the four
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ROBO (1-4) receptors (Legg et al., 2008). The SLIT/ROBO pathway is widely expressed
during development and one of its roles is to function as a repulsive cue in the regulation of
cell migration (Dickinson and Duncan, 2010). It has an evolutionary conserved role in axon
guidance during the development of the nervous system (Hinck, 2004). As well as being
involved in the regulation of cell migration and angiogenesis (Jones et al., 2008), the SLIT/
ROBO interaction can promote cell death through apoptosis (Dallol et al., 2005; Dickinson
et al., 2008). It therefore has particular roles in the development of major organs (Piper et
al., 2000; Hinck, 2004), including the ovary (Dickinson et al., 2010). In addition, the various
mutant mice suffer from multiple developmental abnormalities and the majority die in utero
or shortly after birth (Xian et al., 2001; Grieshammer et al., 2004).
As the SLIT/ROBO interaction inhibits cell migration and promotes cell death, the SLITs
and ROBOs also function as tumour suppressor genes (Dallol et al., 2005; Chetodal et al.,
2005). There is increasing evidence for a loss of SLIT/ROBO expression, mainly through
deletions and promoter region hypermethylation, in multiple cancers including those of the
reproductive system (Dickinson et al., 2004; Narayan et al., 2006). We have recently shown
however that SLITs and ROBOs also have a role in normal adult tissue physiology. We have
reported expression of the SLIT/ROBO pathway in the human corpus luteum across the
luteal phase of the menstrual cycle (Dickinson et al., 2008). The expression of both the
ligands (notably SLIT2 and SLIT3) and receptors (notably ROBO2) peaked during
luteolysis. In addition using in vitro human luteal cell models we showed that the
luteotrophic molecules hCG (Myers et al., 2007a) and cortisol (Myers et al., 2007b)
inhibited their expression. This suggests a regulated role in cyclical tissue remodelling in the
ovary.
The uterus also undergoes tightly regulated cyclical remodelling under the control of
systemic sex steroids and a number of other local factors (Jabbour et al., 2006). During the
menstrual cycle, the endometrium undergoes morphological and functional changes to
prepare for implantation and pregnancy. However the paracrine interaction between the
endometrial cells and the trophoblast to facilitate implantation is not yet fully understood. In
1.3-2% of all pregnancies aberrant implantation occurs in the Fallopian tube. Tubal ectopic
pregnancy remains a major burden on health service resources (Wedderburn et al., 2010)
and continues to be associated with notable maternal morbidity and mortality (Farquhar,
2005). Why the blastocyst implants in the Fallopian tube is not clear as tubal ectopic
pregnancy does not occur in other species (Corpa, 2006; Shaw et al., 2010). There are
however a number of known risk factors such as previous Chlamydia trachomatis infection
and cigarette smoking (Faro, 1991; Bouyer et al., 2003).
As the SLIT/ROBO interaction is a regulated pathway known to be involved in remodelling
in the human ovary, we believe it may also have a functional role in the endometrium and
Fallopian tube. As implantation involves paracrine signalling associated with cell survival
and migration we hypothesised that the repulsive SLIT/ROBO interaction would be
negatively regulated during implantation and that deficient expression in the Fallopian tube
may predispose to ectopic pregnancy. This study therefore aimed to: 1) Examine the
expression and localisation of the SLITs and ROBOs in human endometrium. 2) Determine
if endometrial expression is inhibited at the time of implantation and during early pregnancy
in vivo and study the effects of candidate regulatory molecules in vitro. 3) Examine the
expression and localisation of the SLITs and ROBOs in the Fallopian tube. 4) Determine if
their expression is inhibited in tubal ectopic pregnancy in vivo and study the acute effects of
chlamydial infection and smoking in vitro.
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Materials and Methods
Subjects and tissue collection
Ethical approval was obtained from Lothian Research Ethics Committee and written
informed consent was obtained from all patients. Endometrial biopsies (n = 21) were
collected from fertile women with regular menstrual cycles (25–35 days) who had not
undergone hormonal treatment in the previous three months as described previously (King et
al., 2009). These samples underwent histological dating (Noyes et al., 1950) and were
classified as menstrual (n=3), proliferative (n=5), early-secretory (n=4), mid-secretory (n=5)
and late-secretory (n=4). This corresponded to circulating serum estradiol and progesterone
concentrations as described previously (King et al., 2009). Biopsies from the ampullary
region of the Fallopian tube were collected from a further 17 women undergoing
hysterectomy for benign gynaecological conditions. All had regular menstrual cycles, no
previous history of ectopic pregnancy and had not taken any exogenous hormone
preparations in the three months prior to surgery. These biopsies were also dated with
reference to endometrial histology and serum hormone concentrations. They were classified
as menstrual (n=4), follicular (n=5) and mid-luteal (n=8). In addition, Fallopian tube
biopsies were obtained from six women undergoing surgical management of tubal ectopic
pregnancy [mean gestation 58.09 days ± SD 8.28; mean serum progesterone (P4)
58.53nmol/l ± SD 47.22]. None of these women presented acutely with haemodynamic
shock and all required serial serum βhCG and ultrasound monitoring prior to diagnosis.
Trophoblast-free decidual biopsies (n=6) were obtained from women undergoing therapeutic
surgical termination of pregnancy [mean gestation 69.75 days ± SD 7.07, mean serum P4
61.71 nmol/L ± SD 10.95] as described previously (Horne et al., 2008).
A representative part of each biopsy was immersed in RNAlater storage solution (Ambion,
Texas, USA) at 4C overnight then stored frozen at −80C. A further equal part of the biopsy
was fixed in 4% neutral buffered formalin overnight at 4C, transferred to 70% ethanol and
subsequently embedded into paraffin wax.
RNA extraction and reverse transcription
RNA was extracted from frozen tissue biopsies using the QIAGEN RNeasy Mini Kit and
QIAGEN Tissue Lyser (QIAGEN, Crawley, UK) according to manufacturer’s instructions
and quantified using a ND-1000 spectrophotometer (Nanodrop technologies, DE, USA). All
samples were treated with DNase1 (QIAGEN) to remove genomic DNA contamination.
Reverse transcription (RT) of RNA was performed in 30μl reaction volumes containing
1×RT buffer, 25mM magnesium chloride, dNTPs, random hexamers, RNase inhibitor and
Multiscribe reverse transcriptase (PE Applied Biosystems, Warrington, UK). RT-negative
(containing template RNA but no reverse transcriptase enzyme) and RT water (containing
reverse transcriptase but no template RNA) were included in every cDNA reaction as
negative controls.
Quantitative Real-Time PCR (Q-RT-PCR)
Taqman Q-RT-PCR was used to measure gene expression levels. Specific primers were
designed using the Universal Probe Library Assay Design Center (www.roche-applied-
science.com) and used in conjunction with Universal Probe Library (UPL) probes (Roche
Applied Science). Details of primer sequences and probes used are given in Table 1. All
reactions were performed in triplicate using an ABI 7900 sequence detection system. Using
the 2-ΔΔCt method, mRNA expression results were normalised against ribosomal 18S
internal control (PE Applied Biosystems, Oxford, UK) and expressed as relative expression
compared to cellular or positive tissue controls.
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Immunohistochemistry
Pilot studies showed we could reliably immunolocalise SLIT2, ROBO1, ROBO2 and
ROBO4 using polyclonal antibodies (SantaCruz Biotechnology, Santa Cruz, CA, USA;
Abcam, Cambridge, UK) and peptide-block controls. These proteins (excepting ROBO2 in
the Fallopian tube) were therefore immunolocalised by standard methods using biotinylated
secondary antibodies and ABC-Elite avidin biotin peroxidase complex (Vector Laboratories,
Peterborough, UK) (Dickinson et al., 2010). Briefly, 3μm paraffin sections of endometrium
and Fallopian tube were cut, dewaxed in xylene, rehydrated and subjected to antigen
retrieval by microwaving in Antigen Unmasking Solution (Vector Laboratories) before
blocking endogenous peroxidase with 3% hydrogen peroxidase (Sigma, Dorset, UK). An
avidin-biotin block (Vector Laboratories) and protein block (Dako, Ely, UK) were
performed prior to overnight incubation with primary antibodies. Negative controls were
included in every run where the primary antibody was pre-incubated with a blocking
peptide. Sections were then incubated with biotinylated secondary antibody (Vector
Laboratories) and ABC-Elite (Vector Laboratories). Positive immunostaining was visualised
using 3,3-diaminobenzidine (Vector Laboratories). The stained sections were then
counterstained in haematoxylin, mounted in Pertex (Cellpath PLC, Hemel Hempstead, UK)
and compared to negative control sections.
Cell Culture
The immortalised endometrial epithelial cell line (hTERT-EEpC; Hombach-Klonisch et al.,
2005) was used as an in vitro model to investigate the effects of steroid hormones and hCG.
Cells were maintained in Ham’s F-12 media (Lonza, Basel, Switzerland) supplemented with
10% fetal bovine serum and transferred to serum-free medium overnight prior to treatments.
The cells were treated with concentrations of hCG (10 and 100 IU/ml; Organon
Laboratories, Cambridge, UK) mimicking those at the maternal epithelia adjacent to an
implanting embryo (Horne et al., 2009a; Nakayama et al., 2003). All experiments were
conducted in triplicate and cells were collected after 6 and 24 hours. These time points were
established by our previous studies (Horne et al., 2009a). In addition the cells were treated
with estradiol (E2) (10nM), medroxyprogesterone acetate (MPA) (1μM), vehicle control or
a combination of E2 (10nM) and MPA (1μM) for 24 hours. This treatment regimen has
previously been validated as an in vitro model of steroid action and utilised standard, and
relevant, concentrations of steroids (Horne et al., 2006). Each experiment was conducted
three times and cells were collected after 24 hours.
The OE-E6/E7 oviductal epithelial cell line (Lee et al., 2001) was used to assess the effects
of smoking and chlamydial infection. Cells were maintained in Dulbecco’s modified Eagle’s
medium F12 (Invitrogen Ltd, Paisley, UK) containing 10% fetal calf serum and plated in 48-
well culture plates at a density of 2 × 105 cells/well. Prior to treatment cells were transferred
to serum-free medium overnight. Treatments were then applied in a 500μl volume and
performed in triplicate. Cells were exposed to live C. trachomatis at multiplicities of
infection (MOI) of 0.001, 0.01 and 0.1 for 24 or 48 hours. To control for the presence of
modulatory factors in the oviductal cell lysate resulting from infection, cells were also
exposed to cell lysate (MOI 0). Uninfected cells were included as additional controls.
To assess the effect of smoking we utilised an in vitro approach where cells were treated
with cotinine, a metabolite of nicotine (Conklin et al., 2002). Cells were plated in 12-well
culture plates at a density of 2 × 105 cells/well and transferred to serum-free medium
overnight prior to treatment. Cells were treated with cotinine (Sigma) at a concentration of
either 40ng/mL (representing the concentrations achieved in passive smoking) or 400ng/mL
(representing the concentrations achieved in heavy regular smoking) (Haddow et al., 1987)
or carrier control. Experiments were carried out three times and cells were collected at 4, 8,
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12 and 24 hours. In all culture experiments the cells were collected for subsequent RNA
extraction and analysis of mRNA expression by Q-RT-PCR as described previously. In
these experiments we focussed on assessing the effects on the expression of the primary
ROBO in these cells, ROBO1, and the representative SLIT, SLIT2.
Statistical analysis
Statistical analysis was conducted using a Prism software package (GraphPad Software Inc.,
La Jolla, CA, USA) with significance defined as P<0.05. Analysis was performed using one-
way analysis of variance and Bonferroni’s post-hoc test where three or more variables were
being compared. A t-test was used when two variables were being compared. Where there
were significant differences in variances the data were logarithmically transformed to ensure
normal distribution in all cases prior to statistical analysis.
Results
SLIT/ROBO genes are expressed in human endometrium
Messenger RNA for all known genes in the SLIT/ROBO family was expressed in human
endometrium (Fig. 1). The pattern of expression for each of the SLIT genes was similar
across the menstrual cycle with maximal expression in the mid-secretory phase (Fig. 1a,c,e),
This reached statistical significance for SLIT3 (P=0.0003). The pattern of expression across
the menstrual cycle for ROBO2, ROBO3 and ROBO4 was similar, although it was different
to that of the SLITs (Fig. 1i,k,m). The peak ROBO2, ROBO3 and ROBO4 expression was
seen in the proliferative phase and this reached statistical significance for ROBO2
(P=0.027). Interestingly the pattern of ROBO1 expression was more similar to the SLITs
than the other ROBOs (Fig. 1g). Overall this suggests that endometrial expression of the
SLIT/ROBO system is hormonally regulated and may have a role in the endometrial
function.
SLIT/ROBO gene expression changes after decidualisation
The expression of SLIT2 (P<0.05), SLIT3 (P<0.005), ROBO1 (P<0.05) and ROBO4
(P<0.0005) was reduced in the decidualised endometrium of pregnancy when compared to
the mid-secretory phase (Fig. 1). Unlike other members of the SLIT/ROBO family, SLIT1
(P<0.05) expression, was very low in the non-pregnant endometrium and increased in the
decidualised endometrium of early pregnancy (Fig. 1b). This pattern is consistent with an
inhibition of the endometrial SLIT/ROBO repulsive system during the establishment of
pregnancy.
SLIT and ROBO proteins are localised to the endometrial epithelium
Immunohistochemistry was used to examine the endometrial localisation of candidate SLIT
and ROBO proteins (Fig. 2). SLIT2 and ROBO1 were predominantly expressed in the
surface and glandular epithelium in the human endometrium. ROBO1 (Fig. 2b) and to a
lesser extent SLIT2 (Fig. 2a) could also be detected in individual stromal cells near the
surface epithelium. ROBO2 and ROBO4, the ROBO proteins that demonstrated a slightly
different pattern of mRNA expression across the cycle, were also primarily expressed by
epithelial cells (Fig. 2e,f). ROBO4 could also be localised to stromal cells that appeared to
be endothelial in nature (Fig. 2f). The SLIT/ROBO system is therefore expressed in
endometrial epithelial cells at the stage of the cycle when implantation occurs.
SLIT/ROBO genes are expressed in human Fallopian tube
Expression of the SLIT and ROBO genes, with the exception of ROBO2, could also be
detected in the Fallopian tube across the menstrual cycle (Fig. 3). Although again there was
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a similar pattern of SLIT2 (Fig. 3c) and ROBO1 (Fig. 3b) expression, there were no
statistical differences in expression of any of the SLIT or ROBO genes across the menstrual
cycle (Fig. 3). In addition there was no difference in the levels of expression of the SLIT/
ROBO genes in the Fallopian tubes of patients with tubal ectopic pregnancy (Fig. 3). This
suggests that there may be no reduction in the expression of the SLIT/ROBO system in tubal
implantation.
SLIT/ROBO proteins are expressed by the tubal epithelium
Although there was some faint immunostaining in some smooth muscle and stromal cells,
the primary site of SLIT2 and ROBO1,4 expression in the Fallopian tube, in both the
follicular and luteal phases of the cycle, was the epithelium (Fig. 4). Again the SLIT/ROBO
system seems to be expressed at the epithelial site of ectopic attachment of the conceptus in
the oviduct. However the localisation of SLIT and ROBO in the Fallopian tubes from
women with a tubal ectopic pregnancy was similar to that of the non-pregnant tubes (Fig.
4e,f).
Regulation of SLIT/ROBO expression in the endometrial epithelial cells
In order to investigate factors involved in the regulation of the SLIT/ROBO pathway in the
decidua an immortalised endometrial epithelial cell line was studied in vitro. Neither E2
alone, MPA alone nor a combination of E2 and MPA had any effect on the expression of
SLIT2 over 24 hours (Fig. 5a). ROBO1 was not regulated by either E2 or MPA but a
combination of E2 and MPA inhibited its expression over 24 hours (P<0.01) (Fig. 5b).
Treatment with either 10 or 100IU/mL hCG showed no effect on either SLIT2 (Fig. 5c) or
ROBO1 (Fig. 5d) expression after 6 and 24 hours of culture.
Regulation of SLIT/ROBO expression in oviductal epithelial cells by known risk factors for
ectopic pregnancy
In order to determine if known risk factors for tubal ectopic pregnancy could regulate the
expression of the SLIT/ROBO pathway in tubal epithelial cells an in vitro model was used
to investigate the acute effects of smoking and chlamydial infection. The effect of smoking
on the Fallopian tube was modelled using an oviductal epithelial cell line exposed to
physiological concentrations of cotinine. Treatment with a low dose (40ng/mL;
representative of passive smoking) or a high dose (400ng/mL; representative of regular
smoking) had no effect on the expression of either SLIT2 or ROBO1 at any of the time
points over the 24 h assessment (Fig. 5e,f).
The acute effect of C. trachomatis infection on the SLIT/ROBO pathway in the Fallopian
tube was then investigated using this oviductal epithelial cell line (Fig. 5g,h). There was no
effect on the expression of SLIT2 following infection with C. trachomatis after 24 or 48
hours (Fig. 5g). However there seemed to be a bimodal effect on the expression of ROBO1.
After 24 hours there was a trend for an increase in expression but after 48 hours the
expression of ROBO1 tended to be lower than the control cells. At the highest Chlamydia
inoculation titres there was a significant reduction in ROBO1 expression between 24 and 48
hours exposure (P<0.05) (Fig. 5h).
Discussion
To our knowledge this is the first comprehensive report of the patterns of expression of the
SLIT/ROBO system in the human endometrium and Fallopian tube at different phases of the
menstrual cycle. We also report on SLIT/ROBO expression at normal endometrial and
pathological tubal implantation sites. In addition, we have used an in vitro model system to
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investigate the impact of acute exposure to factors thought to influence implantation on
SLIT/ROBO expression in these tissues.
We demonstrate that all of the known SLITs and ROBOs are expressed in the endometrium
across the menstrual cycle. Only the expression of SLIT3, significantly changed across the
menstrual cycle but each of the SLITs followed the same pattern with maximal expression in
the mid-secretory phase. As each of the SLITs seems to have the same action at each of the
ROBO receptors this suggests a peak of repulsive ligand expression at the time of expected
implantation. This implies that their expression is hormonally regulated and that the SLITs
may have a specific role in endometrial function. However, unlike the corpus luteum
(Dickinson et al., 2008), in the endometrium cell death does not follow the pattern of SLIT
expression. In the endometrium, cell death increases in the late-secretory phase and is
highest during the menstrual phase (Otsuki, 2001; Jabbour et al., 2006). Endometrial tissue
remodelling and angiogenesis however occurs after menstruation, is primarily driven by
estradiol and vascular endothelial growth factor and is largely complete by the mid-secretory
phase (Fraser et al., 2008). It is therefore possible that the peak in SLIT expression at the
mid-secretory phase may reflect or influence this process (Legg et al., 2008). However, the
nature of the role for SLIT in the endometrium remains unclear.
In the corpus luteum, the expression of ROBOs mimics the pattern of expression of the
SLITs (Dickinson et al., 2008). While this was true in the endometrium for ROBO1 and
SLIT1, it was not for the other ROBOs. In the fetal ovary, the SLITs and ROBOs also show
a discrepancy in their pattern of expression (Dickinson et al., 2010). The nature of this
differential expression is unclear but it does suggest that regulation of ROBOs is different to
that of the SLITs in both tissues. However there are receptors to the SLIT ligands in the
endometrium across the menstrual cycle.
Another interesting feature of the ROBOs was the endometrial stromal cell immunostaining.
It has been reported that vascular endothelial cells express ROBO4 (Park et al., 2003; Legg
et al., 2008), and our findings suggest that this is likely to be the case in the human
endometrium but we also demonstrate specific epithelial staining. While SLIT2 could be
detected in some individual cells in the stroma, this was particularly obvious for ROBO1.
The nature of those specific cells is not clear but they may represent immune cells. Certainly
the SLIT/ROBO pathway has previously been described in lymphocytes (Prasad et al.,
2007). However, these undefined immunostained cells were particularly marked in the
proliferative phase and it is the mid-secretory stage that the immune population peaks with
the accumulation of uterine CD56+ve natural killer cells (King, 2000; Jabbour et al., 2006).
While it is attractive to speculate that immune cells are involved in the SLIT/ROBO
interaction in the endometrium, further work needs to be done to confirm this.
As steroids are the primary regulatory molecules controlling the human endometrium
(Jabbour et al., 2006) we hypothesised that they would regulate SLIT/ROBO expression.
Certainly there are steroid response elements on the promoter regions of these genes
(Dickinson RE, unpublished observations) and glucocorticoids inhibit both SLIT and ROBO
expression in ovarian cells (Dickinson et al., 2008). In addition there are steroid receptors on
uterine immune cell populations (Henderson et al., 2003). As progesterone receptors are lost
from endometrial glandular epithelium in the secretory phase (Koh et al., 1995) it is possible
that progesterone is suppressive and that the absence of progesterone receptors is
responsible for the peak in expression at this time. However, MPA alone did not suppress
SLIT2 or ROBO1 and E2 in combination with MPA did not suppress SLIT2 in vitro.
Nonetheless, we did discover that ROBO1 expression was inhibited by the combination of
E2 and MPA. The biological significance of this, and whether the addition of E2 promotes
progesterone receptor expression (Jabbour et al., 2006), is uncertain and requires further
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study. Recently it has been suggested that SLIT/ROBO1 is increased in ovarian
endometriomas (Shen et al., 2009). Sex steroid receptors however are maintained or
increased in ectopic endometrium (Fujishita et al., 1997; Jones et al., 1998). Although it
remains possible that steroids are involved in the physiological regulation of endometrial
SLIT/ROBO we have not been able to fully confirm this in vitro.
We speculated that the SLIT/ROBO system would have a role in the regulation of
implantation. If the system functions as a repulsive cue, that can be regulated, we
hypothesised that endometrial expression of SLITs or ROBOs would be down-regulated
during implantation. Although there was no down regulation during the mid-secretory
implantation window we found some evidence for this in early gestation. The decidualised
endometrium of pregnancy demonstrated a significant reduction in the expression of SLIT2,
SLIT3, ROBO1 and ROBO4. The factors involved in regulating this expression are not clear
but in vitro the decidua is exposed to a combination of estrogen and progesterone as well as
increased local cortisol, as a consequence of HSD11B1 expression (Michael et al., 2003;
McDonald et al., 2006). Increased local cortisol is associated with reduced SLIT/ROBO
expression in the ovary (Dickinson et al., 2008). It is not yet known whether trophoblast
cells express SLIT or ROBO or if trophoblast products can regulate endometrial SLIT or
ROBO expression. We found no evidence for acute regulation by hCG using a treatment
regimen that has been shown to influence endometrial gene expression (Horne et al., 2009a).
It is likely that there is some regulation of the SLIT/ROBO interaction during intrauterine
implantation but the importance and cause of this regulation requires further study.
We have also shown that the SLITs and ROBOs, with the exception of ROBO2 are
expressed in the Fallopian tube and SLIT/ROBO protein is localised to the tubal epithelium.
However, unlike the endometrium there was no change in mRNA expression across the
cycle. Differential regulation of specific proteins in the Fallopian tube compared to
endometrium has also been shown for sex steroid receptors. In contrast to the endometrium,
epithelial steroid receptors are consistently expressed in the Fallopian tube across the
menstrual cycle (Amso et al., 1994; Horne et al., 2009b).
It is not clear if the expression of SLIT and ROBO in the tubal epithelium provides a
repulsive cue to tubal implantation. We did not detect any changes in SLIT/ROBO
expression in the Fallopian tubes of ectopic pregnancy compared to the non-pregnant
Fallopian tube. This might imply that there is no local down regulation of SLITs or ROBOs
in the Fallopian tube by the implanted embryo in contrast to that seen in the endometrium.
However, it is not possible, for ethical reasons, to study the expression of the SLITs and
ROBOs in the Fallopian tube of a woman with an intrauterine pregnancy. Thus, it is feasible
that the reduced sex steroid receptor expression that has been recently observed in the
Fallopian tube of women with ectopic pregnancy (Horne et al., 2009b) may also be seen in
the Fallopian tube in an intrauterine pregnancy.
Thus, the function of the SLIT/ROBO system in the Fallopian tube is unclear. We
hypothesised that, if their function is to inhibit implantation/invasion of ectopic trophoblast
or to affect embryo transport, their expression would be altered by components known to act
as risk factors for ectopic pregnancy such as smoking or chlamydial infection (Farquhar,
2005). We assessed the effect of smoking by exposing oviductal epithelial cells to cotinine,
a bioactive metabolite of nicotine. Cotinine has a much longer half-life than nicotine and has
a similar effect to nicotine in vitro (Conklin et al., 2002). In addition, salivary or serum
concentrations of cotinine have been widely used to establish and quantify an individual’s
exposure of smoking (Haddow et al., 1987). We were therefore able to assess the effects of
biologically relevant concentrations of cotinine. We focussed our Fallopian tube studies on
the representative SLIT2 and ROBO1 molecules and did not see any acute direct effects of
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cotinine on their expression. We have not assessed the effect of other constituents of
cigarette smoke (Rodgman et al., 2000), prolonged exposure, hypoxia, or the impact of other
cells such as immune cells in this study and it remains possible that there are effects in vivo.
However we have not been able to support the hypothesis that the effect of smoking on the
risk of ectopic pregnancy is mediated through acute regulation of SLIT or ROBO
expression.
We also tested whether an acute exposure to C. trachomatis could regulate SLIT2 or
ROBO1 expression. We did not detect any changes to SLIT2 expression after infection with
increasing concentrations of Chlamydia. However, there seemed to be an increase in
ROBO1 expression at the highest infective dose after 24 hours although this was reduced
after 48 hours. To determine whether this is a relevant or important observation requires
further investigation as well as more prolonged study and a comparison of Fallopian tubes
with and without chlamydial infection in vivo. In addition we acknowledge that immune
cells, missing from this model, may mediate some of the endothelial effects of Chlamydia
infection.
To summarise, the demonstration in the human endometrium of temporal expression of
SLITs and ROBOs across the menstrual cycle and of local down regulation during
intrauterine implantation implies an important role for the SLIT/ROBO interaction during
normal endometrial development. This is further evidence that these developmentally
important tumour suppressor genes have physiological roles, with regulated expression, in
the adult female reproductive tract. However, we found consistent expression of SLITs and
ROBOs in the Fallopian tube across the menstrual cycle and in Fallopian tube from women
with ectopic pregnancy. This and the lack of clear regulation in vitro by cotinine or
Chlamydia, do not support our hypothesis that the repulsive SLIT/ROBO system in the
Fallopian tube is dysregulated and implicated in pathological tubal implantation.
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Figure 1.
Expression of SLIT1-3 and ROBO1-4 mRNA in endometrium across the menstrual cycle
(a,c,e,g,i,k,m) and in the decidua of early pregnancy (b,d,f,h,j,l,n). The stages of the cycle
are menstrual (M), proliferative (P), early-secretory (ES), mid-secretory (MS), late-secretory
(LS) and decidua of early pregnancy (D). Different letters represent significant differences
(P<0.05), * represents P<0.05, *** represents P<0.005 and **** represents (P<0.0005).
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Figure 2.
Representative immunolocalisation of SLIT and ROBO proteins (brown) in human
proliferative and mid-secretory endometrium. a) SLIT2 in proliferative phase endometrium.
b) ROBO1 in proliferative phase endometrium where one of the individually stained stromal
cells (black arrow) has been highlighted. c) SLIT2 in secretory phase endometrium. d)
ROBO1 in secretory phase endometrium. e) ROBO2 in secretory phase endometrium. f)
ROBO4 in proliferative phase endometrium where the likely endothelial staining in the
stroma has been highlighted (red arrow). Negative controls are seen in the insets and the
glandular epithelium is labelled (G). Scale bar represents 100 μm (b-e), 75 μm (a) 50 μm
(f).
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Figure 3.
Expression of SLIT1-3 and ROBO1,3&4 mRNA in Fallopian tubes across the menstrual
cycle and in Fallopian tubes from women with ectopic pregnancy. The stages of the cycle
are menstrual (M), follicular (F), luteal (L) and ectopic (E). There were no significant
differences in expression (P>0.05).
Duncan et al. Page 15
Mol Hum Reprod. Author manuscript; available in PMC 2011 June 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 4.
Representative immunolocalisation of SLIT2 and ROBO1 proteins (brown) in human
Fallopian tube. a) SLIT2 in follicular phase Fallopian tube. b) ROBO1 in follicular phase
Fallopian tube. c) SLIT2 in luteal phase Fallopian tube. d) ROBO1 in luteal phase Fallopian
tube. e) SLIT2 in the tube collected from an ectopic pregnancy. f) ROBO1 in the tube
collected from an ectopic pregnancy. Negative controls are seen in the insets and the tubal
lumen is labelled (L). Scale bar represents 100 μm.
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Figure 5.
Manipulation of SLIT2 and ROBO1 expression in vivo. a,b) The effect of estrogen (E2: 10
nM estradiol) and medroxyprogesterone acetate (MPA: 10 nM) in endometrial epithelial
cells (hTERT EEpCs). a) SLIT2 expression does not change after steroid exposure for 24h.
b) ROBO1 expression is reduced (**P<0.01) by a combination of E2 and MPA for 24h. c,d)
The effect of hCG (10 IU/ml and 100 IU/ml) in hTERT EEpCs. c) SLIT2 and d) ROBO1 are
not altered by hCG after 6h (grey bars) or 24h (black bars). d) ROBO1 is also not altered by
hCG after 6h (grey bars) or after 24h (black bars). e,f) The effect of cotinine in oviductal
epithelial cells. There were no significant differences (P>0.05) of treatment with cotinine at
40 ng/ml (grey bars) and 400 ng/ml (white bars) on the expression of SLIT2 (e) and ROBO1
(f) relative to control (black bars) at four different time points up to 24 hours. g,h) The effect
of C. trachomatis exposure in oviductal epithelial cells at different multiplicities of infection
(MOI) for 24 (grey bars) or 48 (black bars) hours on the relative expression of SLIT2 (g)
and ROBO1 (h). A significant difference (P<0.05) in ROBO1 expression between 24 and 48
hours exposure to the highest infective concentration was noted.
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Figure 6.
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Table 1
Primer and Probe combinations used for Taqman Q-RT-PCR.
Forward
Primer
Reverse
Primer
Accession
Number
Probe
Number
ROBO1 aaagtagcacgacggcaaat ggcactgagacgcatgaaa NM_133631.1 89
ROBO2 tttatatgttcgggttgatgga atgacatcggaaggatgctc NM_002942.3 79
ROBO3 cggagtcggagtcagagc acaagggtcatcttggttcct NM_022370.2 21
ROBO4 catcatccgtggctaccag cagttggctggtggcagt NM_019055.4 61
SLIT1 atgagccagctgaccactct gagcggagtccctggaag NM_003061.2 73
SLIT2 catggaggaacttgccactta tccatcagcacaaatacacca NM_004787.1 12
SLIT3 cgagcactgccaacaaga ggcacatgatgcataaccttt NM_003062.1 70
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